Gut Flora: Novel Therapeutic Target of Chinese Medicine for the Treatment of Cardiovascular Diseases.
Gut Flora: Novel Therapeutic Target of Chinese Medicine for the Treatment of Cardiovascular Diseases. Evid Based Complement Alternat Med. 2019;2019:3719596 Authors: Ou Y, Zhang C, Yao M, Wang L Abstract Cardiovascular disease (CVD) is one of the three major threats to human health identified by WHO. Dyslipidemia, hypertension, diabetes, and obesity are well established as common CVD risk factors. However, controversies exist on the effects of gut flora on cardiovascular disease (CVD). Current evidence suggests that gut microbiota is a double-edged sword for CVD risk, and its effects are largely determined by the metabolites of the gut microbiota. Trimethylamine N-oxide (TMAO), as one of the metabolites of gut flora, is consistently associated with higher CVD risk. A few studies have emerged providing early evidence about the safety and efficacy of traditional Chinese medicine (TCM) in treating cardiovascular diseases by regulating gut flora. In this article, we review and interpret the existing evidence as well as explore the potential of intestinal flora as novel therapeutic targets of traditional Chinese medicine for the prevention of cardiovascular disease (CVD). PMID: 31531111 [PubMed]
Conclusion: Septic patients with a past history of heart failure received 1L less IV fluids in the first 24 hours with no difference in mortality.
The objective of this literature review is to present the theoretical and practical aspects of extracorporeal membrane oxygenation support for respiratory and/or cardiac functions in critically ill patients.
Robotic assistance may facilitate completion of minimally invasive hysterectomy, which is the standard of care for the treatment of early-stage endometrial cancer, in patients for whom conventional laparoscopy is challenging. The aim of this systematic review was to assess conversion to laparotomy and perioperative complications after laparoscopic (LH) and robotic hysterectomy (RH) in endometrial cancer patients with obesity.
There are three general techniques for laparoscopic entry, all of which are considered safe and effective. These include the use of a veress needle, an optical trocar, and an open approach. Twenty-five percent of all injuries during laparoscopic surgery occur with initial entry. Therefore, a thoughtful approach to port placement is critical to ensure optimal performance and patient safety with entry. Certain patient factors that may increase the rate of injury or complicate entry include obesity, prior abdominal surgeries, large uterine size, and the small stature and short torso of the pediatric patient.
To evaluate the risk of postoperative complications among diabetic and nondiabetic patients stratified by hemoglobin A1c (HbA1c).
To provide estimates of the prevalence and potential risk factors associated with pelvic organ prolapse (POP) based on Pelvic Organ Prolapse quantification (POP-Q) system and the bother it imposes in a nationwide population-based sample of adult women in China.
To assess the effect of resident participation on hysterectomy-related complications in morbidly obese patients.
To evaluate the accuracy of bladder scanner measurements in assessing post-void residual (PVR) volumes in obese women [body mass index (BMI) ≥30 kg/m2] as compared to non-obese women (BMI
Atypical Hyperplasia carries a 30% risk of developing endometrial cancer over 20 years. Endometrial cancer has increased by 54% since the 1998. Overall hysterectomy rates are falling, and obesity increases. We reviewed 3 snapshot years over 10 years, in terms of hyperplasia numbers, management and surveillance.
To assess the effect of fellowship-trained surgeons (FTS) on hysterectomy-related complications in morbidly obese patients.